Major vitamin manufacturers, including F. Hoffmann-La Roche and others, engaged in a global price-fixing cartel during the 1990s that raised prices for bulk vitamins worldwide. The United States Department of Justice criminally prosecuted aspects of the conspiracy; several defendants pleaded guilty and paid substantial fines. In parallel civil litigation, Empagran S.A. and other foreign purchasers who bought vitamins outside the United States filed a federal class action in the District of Columbia seeking treble damages under the Sherman and Clayton Acts. Plaintiffs alleged a single global conspiracy that had a direct, substantial, and reasonably foreseeable effect on U.S. commerce and also inflated prices abroad; they claimed that the cartel's U.S. overcharges were part of the same worldwide scheme that caused their injuries overseas. The district court dismissed under the FTAIA, holding that the Sherman Act does not apply to non-import foreign commerce unless the U.S. effect gives rise to the claim; the D.C. Circuit reversed, concluding that the statute's reference to an effect that gives rise to "a claim" was satisfied if the conspiracy's U.S. effects spawned any Sherman Act claim by someone (e.g., U.S. purchasers), even if the foreign plaintiffs' own injuries occurred abroad and were independent. The Supreme Court granted certiorari to resolve the scope of the FTAIA's limitation.
Under the FTAIA, may foreign purchasers who suffered injury abroad from a worldwide price-fixing conspiracy bring Sherman Act claims in U.S. courts based solely on the conspiracy's domestic effects on U.S. commerce, even though their injuries are independent of those domestic effects?
The FTAIA, 15 U.S.C. § 6a, provides that the Sherman Act does not apply to non-import foreign commerce unless (1) the conduct has a direct, substantial, and reasonably foreseeable effect on U.S. domestic, import, or certain export commerce, and (2) that domestic effect gives rise to the plaintiff's claim under the antitrust laws. The statutory phrase "gives rise to" requires a proximate causal relationship between the domestic effect and the particular plaintiff's injury; a foreign plaintiff injured abroad cannot sue under the Sherman Act where the foreign injury is independent of any domestic effect. Principles of international comity support this narrow construction.
No. The FTAIA bars foreign purchasers' Sherman Act claims for injuries suffered abroad when those injuries are independent of any domestic effect; the statute requires that the U.S. effect proximately cause the plaintiff's claim.
Text and structure: The Court focused on the FTAIA's two-step limitation and, in particular, the phrase "gives rise to a claim." Reading that phrase to mean that any domestic effect that produces any Sherman Act claim (by anyone) would suffice would effectively erase the FTAIA's restriction and open U.S. courts to a multitude of foreign-injury cases. The Court instead read the statute to require that the specific plaintiff's claim arise from the domestic effect—that is, a proximate causal connection must exist between the U.S. effect and the plaintiff's injury. Comity and practical consequences: The Court emphasized that a broad construction would risk unreasonable interference with the substantive law and enforcement regimes of other nations, many of which provide their own remedies (often without treble damages) for the same conduct. Allowing foreign plaintiffs to recover treble damages in U.S. courts for foreign injuries merely because the same conspiracy affected U.S. markets would undermine international comity, complicate global cartel enforcement, and invite duplicative or conflicting recoveries. A narrower reading protects legitimate global enforcement cooperation without unduly compromising U.S. deterrence interests, which remain served by domestic victims' suits, criminal prosecutions, and government enforcement. Legislative context: The Court viewed the FTAIA as clarifying the extraterritorial reach of the Sherman Act following cases like Hartford Fire. Nothing in the text or history suggested Congress intended the sweeping extraterritorial civil liability urged by plaintiffs. The Court declined to decide questions not presented, such as the meaning of "direct" in the FTAIA or the treatment of import commerce (which the FTAIA does not exclude). Application: Because plaintiffs purchased vitamins abroad and alleged injury from supracompetitive prices in foreign markets, their injuries did not arise from the domestic effect of the conspiracy on U.S. commerce. Even if the cartel's U.S. overcharges were part of a worldwide scheme, the plaintiffs' alleged harm occurred independently of any U.S. price effect. The Court left open the possibility that a plaintiff could plead and prove that a domestic effect proximately caused foreign injury, but it held that independent foreign injuries fall outside the Sherman Act as limited by the FTAIA.
Empagran is the leading case on the FTAIA's "gives rise to" requirement and the extraterritorial scope of U.S. antitrust law. It substantially narrows the path for foreign purchasers to bring treble-damages claims in U.S. courts for injuries suffered abroad, requiring a proximate causal link between a domestic effect and the plaintiff's injury. For practitioners and students, the case underscores the importance of pleading and proof focused on plaintiff-specific causation, the distinction between import commerce and other foreign commerce, and the central role of comity in transnational antitrust enforcement. Empagran also shapes global cartel litigation strategy, often forcing foreign-injury claims to be litigated in non-U.S. fora or to be tethered tightly to U.S. effects.
Empagran draws a clear line around the Sherman Act's application to foreign injuries: when a foreign plaintiff's harm is independent of any U.S. effect, the FTAIA bars suit. By insisting that the domestic effect give rise to the plaintiff's claim, the Court centers proximate causation and limits the extraterritorial reach of U.S. treble-damages litigation.